CXCL13 and primary central nervous system lymphoma: From a clinical point of view, CXCL13 was again confirmed as a reliable marker for CSF B cell recruitment and might be used as a clinical marker to predict disease activity in MS, confirming the diagnosis of LNB and CNS lymphoma [12].